top of page

Search All

MIN

Search by Name

Search by Ticker

Stay updated with the Thesis Tracker newsletter.

BMT

Beamtree Holdings Ltd

Health Care Technology

·

Healthcare

Turn on notifications

About Beamtree Holdings Ltd

Beamtree Holdings Ltd operates in the Healthcare sector in the Health Care Technology industry. Thesis Tracker's coverage of Beamtree Holdings Ltd includes 4 comments from 1 fund manager, like Cyan Investment Management. Beamtree Holdings Ltd., founded in 2018 and headquartered in Redfern, Australia, is an Australian healthcare technology company. It provides proprietary subscription-based clinical decision support (CDS) solutions, including RippleDown, which automates healthcare decision-making based on expert-defined rules. The company operates through four segments: Diagnostic Technology, facilitating personalized medicine; Clinical Decision Support, enhancing care quality and value; Coding Assistance and Data Quality, digitizing workflows to ensure information standardization; and Analytics and Knowledge Networks, which combines data analytics with peer-to-peer alliances to drive innovation. Beamtree leverages AI and expert clinical knowledge to improve healthcare delivery, efficiency, and data accuracy.

Commentary

SOURCE

ACTION

FUND MANAGER

DATE

Cyan Investment Management continues to hold Beamtree Holdings Ltd because the company provided a solid Q3 trading update that included a collaboration with the NHS in the UK, a five-year contract renewal in Ireland worth $3.95 million, a $1 million-plus ARR software installation in a Saudi Arabian hospital, and a forecast of total Annual Recurring Revenue exceeding $30 million entering FY26.

Monthly Report

31 May 2025

.

Cyan Investment Management

No Change

Monthly Report

🔒

Subscribe to unlock the rest.

There are 4 comments from 1 fund manager regarding Beamtree Holdings Ltd (ASX:BMT).

Start a 7 day free trial

Price

$0.12

$0.08

$0.30

Market cap

$35M

Sector

Healthcare

Fund managers

1 manager

First covered

31 May 2024

Last updated

31 May 2025

Company Details

Related Themes

ic

Ipsum Capital

6 comments

ic

Amet Funds

4 comments

ic

Dolor

3 comments

Top Investors Covering MIN

§ Important Notice

The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.

Your Watchlist

🔒

Start tracking companies you care about

Create an account to build a watchlist and get fund manager commentary on the companies you follow.

Start a 7 day free trial

Frequently asked questions about Beamtree Holdings Ltd (ASX:BMT)

Frequently asked questions

Who is investing in Beamtree Holdings Ltd (ASX:BMT)?

Fund managers including Cyan Investment Management have invested in Beamtree Holdings Ltd (ASX:BMT).

What is the short interest in Beamtree Holdings Ltd (ASX:BMT)?

According to ASIC filings, there is negligible or no short interest in Beamtree Holdings Ltd (ASX:BMT).

What does Beamtree Holdings Ltd (ASX:BMT) do?

Beamtree Holdings Ltd., founded in 2018 and headquartered in Redfern, Australia, is an Australian healthcare technology company. It provides proprietary subscription-based clinical decision support (CDS) solutions, including RippleDown, which automates healthcare decision-making based on expert-defined rules. The company operates through four segments: Diagnostic Technology, facilitating personalized medicine; Clinical Decision Support, enhancing care quality and value; Coding Assistance and Data Quality, digitizing workflows to ensure information standardization; and Analytics and Knowledge Networks, which combines data analytics with peer-to-peer alliances to drive innovation. Beamtree leverages AI and expert clinical knowledge to improve healthcare delivery, efficiency, and data accuracy.

bottom of page